M. Y. Hasan

1.5k total citations
70 papers, 1.2k citations indexed

About

M. Y. Hasan is a scholar working on Plant Science, Health, Toxicology and Mutagenesis and Pharmacology. According to data from OpenAlex, M. Y. Hasan has authored 70 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Plant Science, 25 papers in Health, Toxicology and Mutagenesis and 21 papers in Pharmacology. Recurrent topics in M. Y. Hasan's work include Pesticide Exposure and Toxicity (33 papers), Environmental Toxicology and Ecotoxicology (21 papers) and Cholinesterase and Neurodegenerative Diseases (18 papers). M. Y. Hasan is often cited by papers focused on Pesticide Exposure and Toxicity (33 papers), Environmental Toxicology and Ecotoxicology (21 papers) and Cholinesterase and Neurodegenerative Diseases (18 papers). M. Y. Hasan collaborates with scholars based in United Arab Emirates, Czechia and Kuwait. M. Y. Hasan's co-authors include Georg Petroianu, Syed M. Nurulain, Kamil Kuča, Dietrich E. Lorke, Mohamed A. Fahim, Waleed B. Alshuaib, Mohamed Shafiullah, R. Sheen, Kholoud Arafat and Mili Das and has published in prestigious journals such as PLoS ONE, Gut and The FASEB Journal.

In The Last Decade

M. Y. Hasan

68 papers receiving 1.2k citations

Peers

M. Y. Hasan
M. Y. Hasan
Citations per year, relative to M. Y. Hasan M. Y. Hasan (= 1×) peers Cyrus Jalili

Countries citing papers authored by M. Y. Hasan

Since Specialization
Citations

This map shows the geographic impact of M. Y. Hasan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Y. Hasan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Y. Hasan more than expected).

Fields of papers citing papers by M. Y. Hasan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Y. Hasan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Y. Hasan. The network helps show where M. Y. Hasan may publish in the future.

Co-authorship network of co-authors of M. Y. Hasan

This figure shows the co-authorship network connecting the top 25 collaborators of M. Y. Hasan. A scholar is included among the top collaborators of M. Y. Hasan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Y. Hasan. M. Y. Hasan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fahim, Mohamed A., Abderrahim Nemmar, Suhail Al‐Salam, et al.. (2014). Thromboembolic injury and systemic toxicity induced by nicotine in mice. General Physiology and Biophysics. 33(3). 345–355. 16 indexed citations
2.
Lorke, Dietrich E., M. Y. Hasan, Syed M. Nurulain, et al.. (2013). Acetylcholinesterase Inhibitors as Pretreatment Before Acute Exposure to Organophosphates: Assessment Using Methyl-Paraoxon. CNS & Neurological Disorders - Drug Targets. 11(8). 1052–1060. 15 indexed citations
3.
Hartyánszky, István, Huba Kalász, Ernest Adeghate, et al.. (2012). Active Metabolites Resulting from Decarboxylation, Reduction and Ester Hydrolysis of Parent Drugs. Current Drug Metabolism. 13(6). 835–862. 2 indexed citations
4.
Yeatts, Karin, Mohamed El Sadig, David Leith, et al.. (2012). Indoor Air Pollutants and Health in the United Arab Emirates. Environmental Health Perspectives. 120(5). 687–694. 91 indexed citations
5.
Mapanga, Rudo F., Uthra Rajamani, Róisín Kelly‐Laubscher, et al.. (2012). Oleanolic Acid: A Novel Cardioprotective Agent That Blunts Hyperglycemia-Induced Contractile Dysfunction. PLoS ONE. 7(10). e47322–e47322. 42 indexed citations
6.
Rutter, Paul, et al.. (2011). Potential adverse reactions to herbal medicines in patients attending a nephrology clinic in Abu Dhabi, United Arab Emirates.. PubMed. 32(2). 171–6. 2 indexed citations
7.
Kalász, Huba, M. Y. Hasan, Ernest Adeghate, Kornélia Tekes, & Abdu Adem. (2010). Chromatographic separation of antiviral/anticancer nucleoside reverse transcriptase inhibitor drugs. Analytical and Bioanalytical Chemistry. 398(1). 295–312. 2 indexed citations
8.
Lorke, Dietrich E., M. Y. Hasan, Syed M. Nurulain, et al.. (2010). Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors. Journal of Applied Toxicology. 31(6). 515–523. 30 indexed citations
9.
Lorke, Dietrich E., M. Y. Hasan, Kholoud Arafat, et al.. (2008). In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl‐fluorophosphate. Journal of Applied Toxicology. 28(4). 422–429. 37 indexed citations
10.
Lorke, Dietrich E., M. Y. Hasan, Syed M. Nurulain, et al.. (2007). Entry of two new asymmetric bispyridinium oximes (K‐27 and K‐48) into the rat brain: comparison with obidoxime. Journal of Applied Toxicology. 27(5). 482–490. 49 indexed citations
11.
Petroianu, Georg, M. Y. Hasan, Syed M. Nurulain, et al.. (2007). New K-Oximes (K-27 and K-48) in Comparison with Obidoxime (LuH-6), HI-6, Trimedoxime (TMB-4), and Pralidoxime (2-PAM): Survival in Rats Exposed IP to the Organophosphate Paraoxon. Toxicology Mechanisms and Methods. 17(7). 401–408. 21 indexed citations
12.
Petroianu, Georg, Dietrich E. Lorke, M. Y. Hasan, et al.. (2007). Paraoxon has only a minimal effect on pralidoxime brain concentration in rats. Journal of Applied Toxicology. 27(4). 350–357. 35 indexed citations
13.
Johansson, Erland, et al.. (2006). ALTERATIONS IN NICKEL AND CADMIUM CONCENTRATIONS IN ERYTHROCYTES AND PLASMA OF PATIENTS WITH PARKINSON'S DISEASE. 2 indexed citations
14.
Petroianu, Georg, M. Y. Hasan, Syed M. Nurulain, et al.. (2006). Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: Tiapride vs. pyridostigmine. Toxicology and Applied Pharmacology. 219(2-3). 235–240. 13 indexed citations
15.
Petroianu, Georg, Kholoud Arafat, Andrea Schmitt, & M. Y. Hasan. (2005). Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of ranitidine. Journal of Applied Toxicology. 25(1). 60–67. 15 indexed citations
16.
Petroianu, Georg, et al.. (2005). Protective agents in acute high‐dose organophosphate exposure: comparison of ranitidine with pralidoxime in rats. Journal of Applied Toxicology. 25(1). 68–73. 15 indexed citations
17.
Rizk, Diaa E. E., et al.. (2003). Factors influencing the quality of life of infertile women in United Arab Emirates. International Journal of Gynecology & Obstetrics. 80(2). 183–188. 56 indexed citations
19.
Petroianu, Georg, Kholoud Arafat, M. Kosanović, et al.. (2003). In vitro protection of red blood cell acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox). Journal of Applied Toxicology. 23(6). 447–451. 13 indexed citations
20.
Schmassmann, Adrian, A. Garner, Beatrice Flogerzi, et al.. (1994). Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.. Gut. 35(2). 270–274. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026